Mazdutide
<
>
Mazdutide
Mazdutide

Mazdutide


Mazdutide B2B Inquiry Guide

  • Request current specification, packaging, and availability before ordering.
  • Share quantity, destination country, and preferred contact method for a faster quotation.
  • Ask for COA or product-related quality documents during the inquiry process.

This product page is intended for qualified business, laboratory, or research-related inquiry. Availability and permitted use depend on destination country and local regulations.

Mazdutide Procurement Information

Specification Request

Confirm product name, preferred specification, quantity, and packaging requirement before quotation.

Document Support

Ask for available specification sheet, packaging details, or product-related quality documentation.

Quotation Follow-up

Use Inquiry Cart or the quote form so our team can reply with availability, lead time, and shipping communication.

Categories:

  • Description
  • Additional information

Basic Info.


Mazdutide is a dual  agonist  of the GLP-1receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM). 

The drug is developed by Eli Lilly and is currently in multiple Phase III studies.


 In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity.


Request a Quote

Send your quantity, destination country, and preferred contact method. Our team will reply with availability and quotation details.

Categories

Go Back Top